Maxidex
NDC Package 0998-0615-05
Package Information
Maxidex is a medication used to treat certain eye conditions due to inflammation or injury. Marketed by Alcon Laboratories, Inc., this product is identified by NDC 0998-0615 and is authorized under FDA application NDA013422.
Identification & Billing
- RxCUI: 205669 - Maxidex 0.1 % Ophthalmic Suspension
- RxCUI: 205669 - dexamethasone 1 MG/ML Ophthalmic Suspension [Maxidex]
- RxCUI: 205669 - Maxidex 1 MG/ML Ophthalmic Suspension
- RxCUI: 309692 - dexAMETHasone 0.1 % Ophthalmic Suspension
- RxCUI: 309692 - dexamethasone 1 MG/ML Ophthalmic Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0998 - Alcon Laboratories, Inc.
- 0998-0615 - Maxidex
- 0998-0615-05 - 5 mL in 1 BOTTLE, PLASTIC
- 0998-0615 - Maxidex
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0998-0615-05 identifies a specific commercial package of 5 ml in 1 bottle, plastic of Maxidex, labeled by Alcon Laboratories, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alcon Laboratories, Inc. on May 15, 1966. The current certification is valid through August 31, 2023.
What are the primary indications for this medication?
This medication is used to treat certain eye conditions due to inflammation or injury. Dexamethasone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. This medication may also be used to treat swelling, redness, and itching of the outer ear due to inflammatory conditions.
How is this Alcon Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00998061505. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.